MarketInOut Stock Screener Log In | Sign Up

Novogenia AG

XETRA • Healthcare • Biotechnology • Quote as of 11/19/2026 17:35
Novogenia AG stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization66 mln
Float9.00 mln
Earnings Date12/02/2026

EPS

0.05
Overpriced

P / E

106
Highly speculative

Beneish M-Score

41.59
Highly suspicious

Relative Strength

2 / 100
Severely lagging

Debt / Equity

0.06
Debt-free

Pre-Tax Margin

4%
Low margin

Business Description

Founded in 2021 and headquartered in Munich, Germany, Darwin AG sells dietary supplements and cosmetic products while also helping clients through dedicated consulting and support services.

Key Fundamentals

EPS0.05
P/E106
ROE1.06
RPS4.36
ROIC-4.29
ROA0.80
EBITDA, mln6.01
EV / EBITDA5.86
EV / EBIT13.63
Revenue, mln54.30
EV / Revenue0.65

Quote Details

Last 5.30
Change 0.05 (0.95%)
Open 5.25
Volume 15
Turnover 79.5
Average Volume 1,544.52

Financial Ratios

Pre-Tax Profit Margin4
Current Ratio6.00
Price / Book0.79
Price / Tangible Book0.85
Debt / Equity0.06
Price / Sales1.46

Financial Strength

Altman Z-Score4.39
Beneish M-Score41.59
Price to Graham Number1.41

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -17.83% 1 / 100   
1 Month -21.48% 4 / 100   
2 Months -10.92% 17 / 100   
6 Months -19.08% 12 / 100   
1 Year -30.72% 8 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog